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ABSTRACT
Background and objective: Selecting ‘healthy’
preschool-aged children for reference ranges may not
be straightforward. Relaxing inclusion criteria for nor-
mative data does not affect spirometry z-scores. We
therefore investigated the effect of similarly relaxing
inclusion criteria in preschoolers on reference ranges
for respiratory impedance (Zrs) using a modiﬁed forced
oscillation technique (FOT).
Methods: The International Study of Asthma and Aller-
gies in Childhood questionnaire classiﬁed 585 children
into a healthy and ﬁve mutually exclusive groups. Zrs
was measured between 4 and 26 Hz and resistance
(R) and compliance (C) obtained by model ﬁtting. Pre-
diction models were determined using mixed effect
models and z-scores compared between healthy chil-
dren and the ﬁve groups.
Results: Zrs data were obtained for 494 participants
(4.30  0.7 years) on 587 occasions. Comparison of the
Zrs z-scores between the healthy children and the
health groups found signiﬁcant differences in children
with asthma, current wheeze and respiratory symptoms,
but not in children born preterm or with early-life
wheeze. Adding these two groups to the healthy dataset
had no signiﬁcant effect on the distribution of z-scores
and increased the size of the dataset by 22.3%.
Conclusion: Our data suggest that preschool-aged chil-
dren born preterm or with early-life wheeze can be
included in FOT reference equations, while those with
asthma, current wheeze and respiratory symptoms
within 4 weeks of testing should be excluded. This more
inclusive approach results in more robust FOT refer-
ence ranges.
Key words: forced oscillation technique, healthy subjects,
reference values and preschool-aged, respiratory impedance.
Abbreviations: BIS, Barwon Infant Study; BPD,
bronchopulmonary dysplasia; FOT, forced oscillation technique;
ISAAC, International Study of Asthma and Allergies in
Childhood; ORChID, Observational Research in Childhood
Infectious Diseases; Rrs, respiratory resistance; Xrs, reactance;
Zrs, respiratory impedance.
INTRODUCTION
The respiratory system undergoes signiﬁcant growth
and development during the preschool years.1 Being
able to accurately and reliably measure these physio-
logical changes would beneﬁt the diagnosis, treatment
and management of children with suspected or known
respiratory disease. Emphasis should therefore not only
be placed on the lung function measurement itself, but
also on the establishment of reference equations used
to deﬁne normal lung function.2 The unique challenges
of measuring lung function during the preschool years
were addressed previously by developing lung function
tests and reference values speciﬁc to preschool-aged
children.3 However, many of these lung function tests
remain in the research setting and not employed rou-
tinely in clinical practice3,4 due, in part, to challenges in
performing the test and interpreting the results.
The forced oscillation technique (FOT) is employed
widely in the preschool population as a non-invasive
measure of respiratory impedance (Zrs)3–5 and there
are several published reference equations speciﬁc to
this age group.6–27 In general, reference equations are
based on data from ‘healthy’ children, ideally obtained
from an unbiased and representative sample of the
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SUMMARY AT A GLANCE
Normative data for respiratory impedance (Zrs)
measured with the forced oscillation technique in
preschool-aged children use strict criteria to deﬁne
healthy. Zrs z-scores in preterm-births and early-life
wheezers did not differ from healthy children allow-
ing a more inclusive approach for reference equa-
tions, without losing discriminative power for
detecting lung disease.
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population where the test is being administered.28
Whilst the participant characteristics for FOT reference
equations are well-characterized, inconsistencies exist
in exclusion criteria and the deﬁnition of ‘healthy’.
Children with an asthma diagnosis are excluded from
most reference equations,8,10,11,14–16,18–27 while an asthma
family history excluded children from six of these equa-
tions.8,14,15,18,19,21 Other inconsistencies in exclusion cri-
teria include the time interval following a respiratory
infection,8,10–16,18,19,21,22,24–26 a history of wheeze and
preterm-birth.18,21,24–26 These inconsistencies in exclu-
sion criteria (Table 1), between different reference
equations highlight the challenges of deﬁning and
identifying ‘healthy’ preschool-aged children when
developing reference equations.
So, how ‘healthy’ does a child have to be for inclu-
sion in reference equations for lung function measure-
ments? A previous study examined the inﬂuence of
exclusion criteria on spirometry z-scores in children
aged 5–11 years of age.30 It found that including chil-
dren normally excluded from normative data (born
preterm, low-birth weight, prior asthma or being mildly
symptomatic at the time of measurement) did not sub-
stantially alter the overall z-scores for forced expiratory
volume in 1 s (FEV1) and forced vital capacity (FVC).
Adding these children who are typically excluded from
‘healthy’ reference equations increased the sample size
by 25%. This more inclusive approach to deﬁning
populations for establishing reference equations allows
a more generalizable reference set, and is potentially
more representative of patients in the clinical setting.
We therefore investigated whether preschool-aged
children with: doctor-diagnosed asthma, early-life or
current wheeze, preterm-birth or respiratory infection
within 4 weeks of the study visit could be included in
FOT reference equations developed for preschool-aged
children without compromising the integrity of the
equations. We also used the outputs from ﬁtting a
model to the Zrs spectrum to derive the resistive
parameter R, representing the frequency-independent
Newtonian resistance and C, characterizing compliance
of the respiratory system during tidal breathing.
METHODS
Preschool children, aged 3–6 years from an urban set-
ting were recruited from kindergartens in Brisbane,
Australia and from community birth cohort studies; the
Observational Research in Childhood Infectious Dis-
eases study (ORChID), Brisbane, Australia31 and the
Barwon Infant Study (BIS), Geelong, Australia.32 Chil-
dren were also recruited from a local kindergarten in
Szeged, Hungary. To optimize recruitment in kinder-
gartens, parents of all attendees aged 3–6 years
received recruitment packages (parent information
sheet, consent form and a modiﬁed International Study
of Asthma and Allergies (ISAAC) questionnaire33) and
were asked to return the completed consent form and
questionnaire before the study visit. The child’s guard-
ian was not required to be present at the study visit.
The Children’s Health Queensland (HREC/12/QRCH/
23), The University of Queensland (2014000212), the
Barwon Health (10/24) and the Hungarian Regional
(107/2015-SZTE) Human Ethics Committees approved
the study.
Clinical deﬁnitions
Inclusion criteria for ORChID and BIS included: healthy
at birth, without a major congenital abnormality or
serious illness identiﬁed in the ﬁrst days of life (BIS)
and born at >36 weeks (ORChID) and >33 weeks (BIS)
gestation. Whereas, all children aged 3–6 years from
the kindergartens were eligible for recruitment, and
children diagnosed with a chronic respiratory illness
other than asthma, a congenital abnormality affecting
their ability to stand or a disorder compromising lung
development were excluded. ‘Healthy’ children fulﬁlled
the following criteria: born term (≥37 weeks gestation),
free of any respiratory symptoms and no respiratory
medication use within 4 weeks of the study visit, had
never wheezed and no prior doctor-diagnosed asthma.
Children who did not ﬁt these criteria were classiﬁed
into one of ﬁve groups; doctor-diagnosed asthma, cur-
rent wheeze (wheeze episodes in the past and the last
12 months), early-life wheeze (wheeze episodes in the
past, but not in the last 12 months), children born pre-
term (<37 weeks gestation) and the respiratory symp-
tom group (children with upper or lower respiratory
infections within 4 weeks of the study visit). Classiﬁca-
tions were determined from the modiﬁed ISAAC and
were mutually exclusive with children assigned to the
most abnormal; e.g. a child born preterm with current
wheeze and an asthma diagnosis was included in the
‘asthma’ group.
Measurements of Zrs
Zrs was measured using custom made FOT equipment
incorporating a wave-tube and a loudspeaker,34 in
accordance with the American Thoracic Society/Euro-
pean Respiratory Society guidelines.3 Measurements
were obtained using a pseudorandom signal between
4 and 26 Hz. Children breathing tidally whilst wearing
a nose-clip, had their cheeks ﬁrmly supported and a
tight seal around an antibacterial mouthpiece (Bird
Healthcare, Melbourne, Victoria, Australia). A mini-
mum of three, 16-s artefact free and reproducible mea-
surements were obtained and from these the Zrs
spectra were ensemble averaged. A resistance (R)–
compliance (C)–inertance (I) model was ﬁtted to the
averaged Zrs spectra: Zrs = R + jωI + (1/jωC), where j is
the imaginary unit and ω is angular frequency; R was
calculated between 10 and 20 Hz from the respiratory
resistance (Rrs) data, while C and I were estimated
between 6 and 26 Hz from the reactance (Xrs) data.35
Statistical analysis
Demographic and anthropometric data are presented
as median and 25th–75th percentiles. Lung function
variables were not normally distributed and all Xrs var-
iables were transformed to absolute values. To achieve
normality all Zrs variables underwent natural
logarithmic-transformation prior to analysis. Differ-
ences in lung function between healthy children and
children in other health groups were assessed using
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Table 1 Exclusion criteria for determining the selection of children included in reference equations for FOT adapted
from Stanojevic29
Reference
Signal and
frequency (Hz) n
Age
(years) Exclusion criteria to deﬁne ‘healthy’
Williams et al. (1979)7 Pseudorandom 15–35 Hz 16 3–5 Not stated.
Morgan et al. (1982)8 Pseudorandom 2–15 Hz 101 3–5 Family or personal history of asthma, respiratory
symptoms at testing.
Duiverman et al. (1985)9 Pseudorandom 2–26 Hz 255 2–12 Wheeze (present and/or past), recurrent cough.
Hantos et al. (1985)10 Pseudorandom 3–10 Hz 121 4–16 History of respiratory disease, acute respiratory
symptoms at testing.
Hordvik et al. (1985)11 Pseudorandom 2–26 Hz 138 2–16 History of chronic or systemic disease affecting the
respiratory system, acute respiratory symptoms
(within 3-weeks of testing), more than incidental
smoke exposure.
Solymar et al. (1985)12 Single frequency
2,4,12 Hz
218 2–18 History of recurrent cough, wheeze, pneumonia,
cardiac disease, recent respiratory infection and
cigarette smoke exposure.
Lierl and Hilman (1986)13 Pseudorandom 2–26 Hz 90 4–7 History of respiratory disease, respiratory symptoms
at testing.
Lebecque et al. (1991)14 Single frequency 10 Hz 377 3–18 Prior history of wheeze or use of bronchodilators,
chronic cough, exercise intolerance, frequent or
severe upper respiratory tract infections URTI’s,
use of cigarettes, major thoracic or cardiac
disorders, familial history of asthma, respiratory
symptoms within 4-weeks of testing.
Ducharme et al. (1998)15 Single frequency
8,12,16 Hz
200 3–17 Personal or family history of wheeze, asthma,
allergic rhinitis or dermatitis, low birth weight,
preterm-birth (<37-weeks), bronchopulmonary
dysplasia, neonatal ventilation, active or passive
smoke exposure, obesity, upper respiratory tract
infection, dyspnoea, cough, wheeze, SpO2 < 95%.
Klug et al. (1998)16 Square-wave 5–35 Hz 121 2–7 Chronic disease, history of recurrent cough, wheeze,
severe pneumonia, eczema, atopic ﬁrst degree
relatives, signiﬁcant exposure to tobacco smoke
(>3 cigarettes a day), respiratory symptoms within
4-weeks of testing.
Hellinckx et al. (1998)27 Impulse
5–35 Hz
247 3–6 A scoring system to deﬁne asthma that considered
history of wheeze, shortness of breath, cough,
asthma diagnosis and the use of respiratory
medications
Frei et al. (2005)18 Impulse 5–35 Hz 222 3–10 Same exclusion criteria as Ducharme et al.15
Dencker et al. (2006)19 Impulse 5–35 Hz 360 2–11 Past or present chronic respiratory disease, family
history of asthma, respiratory symptoms within 2-
weeks of testing.
Hall et al. (2007)20 Pseudorandom 4–48 Hz 158 2–7 Doctor-diagnosed or parent reported respiratory
disease, asthma or wheeze (past or present),
parent reported cough in last 12-months.
Nowowiejska et al. (2008)21 Impulse 5–35 Hz 626 3–19 Same exclusion criteria as Ducharme et al.15
Vu et al. (2008)22 Single frequency 8 Hz 175 6–11 History (past and present) of wheeze, acute
respiratory symptoms at testing.
Amra et al. (2008)23 Square-wave 5–25 Hz 509 5–18 Past or current history of respiratory disease
(including asthma), lifelong history of smoking
100 or more cigarettes
Calogero et al. (2010)25 Pseudorandom 4–48 Hz 163 2–6 Preterm-birth (<36-weeks), supplemental O2 after
birth for more than 30 days, doctor diagnosed
asthma, >3 wheeze episodes ever or wheeze in the
past 12-months and free of respiratory symptoms
and sing at the time of testing.
Calogero et al. (2013)24 Pseudorandom 4–48 Hz 760 2–13 Preterm-birth (<36-weeks), supplemental O2 at birth,
doctor diagnosed-asthma, >3 wheeze episodes
ever or wheeze in the past 12-months, respiratory
symptoms within 3-weeks of testing
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Student’s t-test. Normative equations were calculated
using mixed-effects linear regression modelling. Mixed-
effects models were used as data points from some
children from the ORChID Study were included more
than once. Initially, successive univarible models with
height, weight, age and sex were included as the main
effect were constructed. Then, multivariable models
were built using combinations of main effects, before
the most parsimonious multivariable model was
selected using the likelihood ratio test. In all models,
each child was included as a random effect, to account
for the probable non-independence of observations
from the same child. Z-scores were calculated using
the equation: Z = (measured − predicted)/SD, where
SD represents the overall standard deviation of the
model. The inﬂuence of adding successively ‘less
healthy’ children to the data set was determined by
recalculating the regression equations and z-scores and
comparing the z-scores between the newly deﬁned
healthy children and the children in other health
groups to those obtained from the original equation.
RESULTS
A total of 494 children (mean age 4.30  0.68 years)
provided 587 analysable measurements of lung func-
tion; 31 children were measured twice; 28 measured
three times and 2 children were measured four times,
all on separate testing occasions. The overall feasibility
percentage was 85.5% (670 testing occasions in total).
Reasons for failure are detailed in Figure 1. Feasibility
was marginally lower in children aged 3–4 years
(85.2%) than 5–6 years of age (88.1%).
Demographic and clinical characteristics of the
health groups are summarized in Table 2, and lung
function is shown in Table 3 for the common FOT out-
come variables as well as for R and C. The full range of
Zrs variables are shown in Table S1 in Supplementary
Information. Signiﬁcant differences in lung function
variables were detected between ‘healthy’ children and
children with asthma (Rrs8 P = 0.044 and Xrs10
P = 0.025), children born preterm (Xrs6 P = 0.011 and
Table 1 Continued
Reference
Signal and
frequency (Hz) n
Age
(years) Exclusion criteria to deﬁne ‘healthy’
Gochicoa-Rangel et al.
(2015)26
Impulse 5–20 Hz 283 2–15 Presence of chronic illness including heart, liver
kidney and respiratory disease (asthma, wheezing
and rhinosinusitis). Past history of prematurity,
pneumonia, bronchiolitis and regular exposure to
environmental tobacco smoke or biomass smoke.
Absence of acute respiratory morbidity within
15 days of testing and without suspicion of sleep
apnoea/hypopnea or gastro-oesophageal reﬂux.
Age (years) presented as range.
SpO2, Oxygen saturation level as measured by pulse oximetry; URTI, Upper Respiratory Tract Infection.
Consent obtained n = 599
FOT testing occasions n = 714
Excluded n = 44
- Absent on day of testing n = 11
- ISAAC questionnaire not completed n = 19
- Incomplete ISAAC questionnaire n = 4
- Unable to measure height n = 10
Testing occasions n = 670
- Healthy n = 335
- Asthma n = 78
- Recurrent wheeze n = 85
- Early life wheeze n = 53
- Pre-term n = 41
- Respiratory symptoms n = 78
Acceptable spectral FOT measurements n = 587
- Healthy n = 295
- Asthma n = 70
- Recurrent wheeze n = 71
- Early life wheeze n = 49
- Pre-term n = 32
- Respiratory symptoms n = 67 
Excluded n = 83
- Equipment/user error n = 16
- Participant unwilling to co-operate n = 32
- FOT measurements not acceptable or
   repeatable n = 35
Figure 1 Participant ﬂow
through the study. FOT, forced
oscillation technique; ISAAC,
International Study of Asthma
and Allergies.
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Xrs8 P = 0.038), children with current wheeze (Xrs6
P = 0.046, Xrs8 P = 0.013 and Xrs10 P = 0.004) and in
children with respiratory symptoms (R P = 0.037 and
Rrs10 P = 0.046), with the major differences seen in the
6–10 Hz range (Table 3).
For the traditional approach of deﬁning ‘healthy’, all
Zrs variables were signiﬁcantly associated with height
only (P < 0.001) (Table S2 in Supplementary Informa-
tion). Z-scores calculated for each group using this
analysis are shown for the commonly reported vari-
ables in Table 4. Compared to ‘healthy’ children, the
asthmatic children had signiﬁcantly different z-scores
at R (P = 0.049), Rrs6 (P = 0.029), Rrs8 (P = 0.024),
Rrs10 (P = 0.032), C (P = 0.015), Xrs6 (P = 0.047) and
Xrs10 (P = 0.016). Whereas children classiﬁed as cur-
rent wheezers were signiﬁcantly different at Rrs6
(P = 0.031), Xrs8 (P = 0.011) and Xrs10 (P = 0.013) and
children with respiratory symptoms within 4 weeks of
the FOT measurements had signiﬁcantly different z-
scores at R (P = 0.014), Rrs8 (P = 0.012) and Rrs10
(P = 0.012).
The lack of signiﬁcant differences in Zrs z-scores
detailed in Table 4 between healthy children and chil-
dren with early-life wheeze and those born preterm
validated a more inclusive approach to deﬁning
healthy, increasing the healthy data set by 71 children.
Prediction equations generated based on the newly
deﬁned healthy group are provided in Table S3 in Sup-
plementary Information, and the relationship between
R and C against height in Figure 2. Signiﬁcant differ-
ences in the mean z-scores between the newly deﬁned
healthy children and children with asthma
(R (P = 0.042), Rrs6 (P = 0.024), Rrs8 (P = 0.016), Rrs10
(P = 0.025), C (P = 0.035) and Xrs10 (P = 0.022)), with
Table 2 Demographic and anthropomorphic characteristics of participants with acceptable and repeatable forced
oscillation technique measurements
Healthy Asthma
Current
wheeze
Early-life
wheeze Pre term birth
Respiratory
symptoms
n 248 59 50 39 32 66
Gestational Age
(weeks)
40 (39; 40.6) 39 (38; 41) 39.2 (38; 40.4) 40 (39; 40.2) 36.1 (33.5;37.0) 40 (39; 40.3)
Male (n) 126 33 33 20 15 36
Age (years) 4.1 (4.0; 4.7) 4.2 (4.0; 4.6) 4.2 (3.9; 4.7) 4.5 (3.9; 5.1) 4.3 (4.0; 4.8) 4.3 (3.9; 4.7)
Height (cm) 105.3
(102.0; 109.9)
106.8
(102.8; 109.9)
105.5
(101.4; 110.0)
108.1*
(103.0; 113.4)
103.08
(99.8; 107.1)
105.5
(101.0; 109.5)
Weight (kg) 17.2
(15.8; 19.1)
17.8*
(16.1; 20.0)
17.2
(16.0; 19.0)
18.9*
(16.5; 21.0)
16.6
(15.2; 17.9)
17.5
(16.1; 19.0)
Data presented as median (25; 75%) in a study population in which 92% identify as Caucasian.
*P < 0.05 compared to the healthy children. Preterm-birth (<37-weeks) and none diagnosed with bronchopulmonary dysplasia.
Table 3 Zrs variable for 6, 8 and 10 Hz for each of the health groups
Healthy Asthma Current wheeze
Early-life
wheeze Pre term birth
Respiratory
symptoms
n 248 59 50 39 32 66
R (hPa s/L) 8.27
(7.25; 9.23)
8.37
(7.49; 9.81)
8.52
(7.57; 9.54)
7.86
(7.10; 9.00)
8.53
(7.63; 9.87)
7.79*
(6.77; 8.95)
Rrs6 (hPa s/L) 9.47
(8.28;10.61)
9.71
(8.94;11.45)
10.04
(8.78;11.68)
9.63
(7.99;10.78)
9.99
(8.94;11.04)
9.00
(7.61;10.67)
Rrs8 (hPa s/L) 9.18
(7.99;10.27)
9.57*
(8.52;10.90)
9.56
(8.41;10.81)
8.88
(7.95; 9.98)
9.05
(8.50;10.66)
8.55
(7.30;9.93)
Rrs10 (hPa s/L) 8.76
(7.82;9.87)
9.04
(8.26;10.48)
9.13
(8.22;10.56)
8.38
(7.74;9.80)
8.84
(8.02;10.23)
8.24*
(7.22;9.61)
C (hPa s mL−1) 8.03
(6.59;9.92)
7.62
(5.84;8.98)
7.81
(5.91;10.80)
8.47
(6.52; 10.76)
7.57
(4.95;9.60)
7.89
(6.75;10.55)
Xrs6 (hPa s/L) −2.92
(−3.70; −2.35)
−3.21
(−4.10; −2.46)
−3.14*
(−4.06; −2.51)
−3.24
(−3.73; −2.11)
−3.21*
(−4.70; −2.46)
−2.83
(−3.88; −2.30)
Xrs8 (hPa s/L) −2.24
(−2.88; −1.71)
−2.46
(−3.04; −1.83)
−2.50*
(−3.58; −1.89)
−2.34
(−3.20; −1.53)
−2.62*
(−3.86; −1.89)
−2.20
(−3.18; −1.59)
Xrs10 (hPa s/L) −1.94
(−2.60; −1.39)
−2.25*
(−2.98; −1.55)
−2.22*
(−3.33; −1.70)
−1.96
(−2.59; −1.20)
−2.23
(−3.41; −1.44)
−1.87
(−2.54; −1.10)
Raw Zrs (Rrs and Xrs) data presented as median (25; 75%). Preterm-birth (<37-weeks) and none diagnosed with bronchopulmonary
dysplasia.
*Signiﬁcant difference from healthy group, P < 0.05.
C, compliance of the respiratory system; R, frequency-independent Newtonian resistance; Rrs, respiratory resistance; Xrs,
reactance.
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current wheeze (Rrs6 (P = 0.031), Xrs8 (P = 0.021) and
Xrs10 (P = 0.019)) and children with respiratory symp-
toms within 4 weeks of the FOT measurements (Rrs6
(P = 0.041), Rrs8 (P = 0.009), Rrs10 (P = 0.009) and
Xrs10 (P = 0.031)) (Table S4 in Supplementary Infor-
mation) were still signiﬁcant after including children
with early-life wheeze and children born preterm to
the normative healthy data set.
DISCUSSION
A more inclusive approach to selecting children for
developing FOT reference equations is possible without
compromising test performance. This more inclusive
approach to deﬁning healthy preschool-aged children
had no effect on the healthy group’s FOT z-score distri-
butions or on the ability to differentiate healthy chil-
dren from children with asthma, current wheeze or
those with respiratory symptoms within 4 weeks of
FOT measurements. Combining the Zrs measurements
of children with early-life wheeze and born preterm
with the healthy children together to form a newly
deﬁned healthy normative group is more generalizable
to the preschool-aged population in which FOT is
being measured. Despite these children representing a
small proportion of the study cohort, their inclusion to
the normative data set increased the healthy popula-
tion by 22.3%, which to our knowledge makes this FOT
reference set the largest published in Caucasian
preschool-aged children.
Reference equations have typically applied strict
criteria when deﬁning a healthy population. But, as
our study suggests this strict approach may not
be required when establishing normative FOT refer-
ence data. Currently, published FOT reference
equations9,12,14–16,18,20–22,24–26 excluded participants with a
history of wheeze, whereas our data indicate that this
is unnecessary in the preschool age range. This more
inclusive approach is better reﬂective of the preschool
population where wheeze with or without a viral illness
is also commonly reported but has shown to be tran-
sient with minimal effects into older childhood.36 Data
from the present study document that including chil-
dren with wheeze in early-life, but without wheeze in
the past 12-months does not adversely inﬂuence the
reference equations. In many cross-sectional studies,
especially in older children, parents may have forgotten
mild episodes of wheeze in early-life. Our data suggest
this does not matter. Children born preterm are
another group often excluded from FOT normative data
sets (Table 1). Studies undertaking FOT measurement’s
in children born preterm report reduced lung function
compared to healthy children, which is independent of
a history of bronchopulmonary dysplasia (BPD),3738–40
In the present study, lung function in 32 children born
preterm (<37-weeks) was comparable to healthy chil-
dren. The median (25; 75%) gestational age of children
born preterm in the present study was 36.1 (33.5; 37.0)
weeks, whereas the studies reporting worse lung func-
tion in children with or without BPD were born at a
much earlier gestation (<32-weeks). Although the num-
ber of children born preterm in this study is small our
data suggest that children born between 34 and 37-
weeks gestational age, should be included in normative
FOT reference data, whereas children born very pre-
term (<32-weeks) should not. Consideration is also
given to respiratory symptoms when selecting healthy
children for inclusion in reference ranges. Yet estab-
lishing an asymptomatic period in preschool-aged chil-
dren can be difﬁcult. Children attending childcare have
increased exposure to other children and a greater risk
of acute respiratory tract infections.31,41,42 Interestingly,
in our cohort children with upper or lower respiratory
infections had better lung function compared to
healthy children. There are many possible explanations
for this observation, all of which highlight the special
requirements for collecting lung function data in the
ﬁeld in preschool-aged children. In this study, children
were classiﬁed as having a respiratory infection if
symptoms occurred within 4 weeks of the study visit.
These data were obtained from a modiﬁed version of
the ISAAC questionnaire administered before the study
visit. Time between completing the ISAAC question-
naire and the study visit may have meant respiratory
symptoms had subsided and medication used during
Table 4 Mean (SD) z-scores calculated for each group using reference equations obtained using the conventional
deﬁnition for healthy children
Healthy Asthma
Current
wheeze
Early-life
wheeze
Preterm-
birth
Respiratory
symptoms
n 294 70 71 49 32 67
R (hPa s/L) −0.01 (1.00) 0.25* (1.02) 0.15 (0.92) −0.09 (1.01) 0.11 (0.95) −0.35* (1.10)
Rrs6 (hPa s/L) −0.03 (1.00) 0.27* (1.07) 0.25* (0.96) 0.06 (1.00) 0.05 (0.86) −0.30 (1.14)
Rrs8 (hPa s/L) −0.03 (0.99) 0.27* (1.07) 0.14 (0.91) −0.10 (0.96) 0.03 (0.92) −0.38*(1.10)
Rrs10 (hPa s/L) −0.02 (0.99) 0.27* (1.06) 0.19 (0.96) −0.08 (1.01) −0.02 (0.92) −0.37*(1.12)
C (hPa s mL−1) 0.03 (1.00) −0.31* (1.19) −0.21 (1.21) 0.06 (1.01) −0.23 (1.23) 0.22 (0.96)
Xrs6 (hPa s/L) 0.01 (1.00) −0.26* (1.38) −0.32 (1.14) −0.01 (1.01) −0.37 (1.18) 0.10 (1.06)
Xrs8 (hPa s/L) 0.00 (0.99) −0.22 (1.17) −0.33* (1.01) −0.04 (1.06) −0.24 (1.03) 0.08 (1.02)
Xrs10 (hPa s/L) 0.03 (0.99) −0.30* (1.03) −0.25* (1.01) 0.00 (0.98) −0.05 (1.23) 0.29 (0.96)
Preterm-birth (<37-weeks) and none diagnosed with bronchopulmonary dysplasia.
*Signiﬁcantly different from healthy children P < 0.05.
C, compliance of the respiratory system; R, frequency-independent Newtonian resistance; Rrs, respiratory resistance; Xrs,
reactance.
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this symptomatic period might have improved lung
function.
One of the factors limiting greater uptake of FOT in
clinical practice may be the outcome variables
reported. Clinicians have a concept of resistance, but
the reporting of Rrs6, Rrs8 and Rrs10 begs the ques-
tions ‘do they provide different information’ and ‘if not,
why report three values?’ Xrs as a concept is more
challenging, especially as it has, by convention a nega-
tive value at low frequencies. Worse lung function is
associated with more negative Xrs. In an attempt to
make FOT more ‘user friendly’, we included a model-
ling approach to produce single values for R and C, a
concept more easily understood as C reﬂects the dis-
tensibility of the respiratory system. And although C is
a robust parameter more easily understood than Xrs, it
should be treated with caution in the presence of air-
way obstruction. When ﬁtting the hyperbolic model
for C, the negative component of the Xrs curve is
selected and is ﬂatter in appearance compared to
healthy controls, increasing the model ﬁtting error. In
the present study, there is essentially no difference in
the clinical message from FOT, whether considering
the traditionally reported single-frequency values of
Rrs6, Rrs8, Rrs10, Xrs6, Xrs8, Xrs10 or the more com-
prehensive R and C derived from the simple
resistance–compliance–inertance concept of respiratory
mechanics. Accordingly, we have reported normative
equations for both sets of data allowing comparisons to
be made.
In summary, the data from the present study suggest
a more inclusive and realistic approach can be taken to
deﬁne a healthy population when developing FOT
reference equations, without losing discriminate power
for detecting lung disease.
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